Skip to main content

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

Feedback
Newsletter
RSS
Twitter

User Top Menu

Welcome, guest
Log In
Join
Why Join?

Search form

Search

About Us
- Overview
- Who We Are
- Contact
- Fan Mail
- How to Cite
News & Future Directions
Papers
Forums
- Discussions
- Webinars
Professional Resources
Research Resources
Click Here to Support MSDF

You are here

Most Viewed

Multiple sclerosis: Preventing progression and disability in MS-when to treat?
White matter disease: Early treatment of inflammatory demyelinating disease.
Genetic variation associated with the occurrence and progression of neurological disorders.
An unusually dry story.
Placebo controlled trials in neuromyelitis optica are needed and ethical.
Prox1 Inhibits Proliferation and Is Required for Differentiation of the Oligodendrocyte Cell Lineage in the Mouse.
Alternative source of stem cells derived from human periodontal ligament: a new treatment for experimental autoimmune encephalomyelitis.
Nudging Oligodendrocyte Intrinsic Signaling to Remyelinate and Repair: Estrogen Receptor Ligand Effects.
Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin.
Human neural progenitor cells in central nervous system lesions.
Dexterity, visual perception, and activities of daily living in persons with multiple sclerosis.
Aging with a disability and state vocational rehabilitation services.
Design of Peptide Immunotherapies for MHC Class-II-Associated Autoimmune Disorders.
[New challenges in multiple sclerosis treatment].
A Mutation in PMP2 Causes Dominant Demyelinating Charcot-Marie-Tooth Neuropathy.
Transverse Myelitis.
Altered Effective Connectivity during a Processing Speed Task in Individuals with Multiple Sclerosis.
Adult-Onset Leukoencephalopathies.
Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis Therapy.
Multifocal VEP assessment of optic neuritis evolution.
Analysis of the treatment of neuromyelitis optica.
Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 - 2014).
Emerging roles of microRNAs in chronic pain.
Oligodendrocyte gap junction loss and disconnection from reactive astrocytes in multiple sclerosis gray matter.
A clinical and radiological profile of neuromyelitis optica and spectrum disorders in an Indian cohort.

Pages

« first
‹ previous
…
534
535
536
537
538
539
540
541
542
…
next ›
last »

MSDF Footer

Copyright © 2014 MGH and ACP

Privacy
Terms of Use
How to Cite
FAQ/Help
Site Map
Support Us
Feedback
Image Credits

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Content By

Software By